Antitumor Phthalanilides Active in Acute and Chronic Trypanosoma Brucei Brucei Murine Infections

Henry C. Nathan Biology Department and Haskins Laboratories of Pace University, New York, New York 10038

Search for other papers by Henry C. Nathan in
Current site
Google Scholar
PubMed Close
,
Cyrus J. Bacchi Biology Department and Haskins Laboratories of Pace University, New York, New York 10038

Search for other papers by Cyrus J. Bacchi in
Current site
Google Scholar
PubMed Close
,
Charles A. Nichol The Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709

Search for other papers by Charles A. Nichol in
Current site
Google Scholar
PubMed Close
,
David S. Duch The Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709

Search for other papers by David S. Duch in
Current site
Google Scholar
PubMed Close
,
Elizabeth A. Mullaney Biology Department and Haskins Laboratories of Pace University, New York, New York 10038

Search for other papers by Elizabeth A. Mullaney in
Current site
Google Scholar
PubMed Close
, and
Seymour H. Hutner Biology Department and Haskins Laboratories of Pace University, New York, New York 10038

Search for other papers by Seymour H. Hutner in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1984.33.845
Volume/Issue:
Volume 33: Issue 5
Page(s):
845–850
Restricted access
Get Permissions

A series of phthalanilides and related compounds were tested on a short-term, fulminating, mouse infection of Trypanosoma brucei brucei (EATRO 110 isolate). The most effective compound was [4,4′-bis(4-methylimidazolin-2-yl)-terephthalanilide] which had a cure rate of 75% at 0.1 mg/kg body weight and 100% at 0.5 mg/kg when administered as three single daily intraperitoneal injections starting 24 hours post-infection. Several related phthalanilides and similarly substituted ureas showed definite but lower activity. In tests with a chronic neurotropic T. b. brucei isolate (TREU 667), cure rates greater than 90% were obtained with 10 or 25 mg/kg [4,4′-bis(4-methylimidazolin-2-yl)-terephthalanilide]. Cured animals survived for at least 200 days after infection with no evidence of recrudescence of parasitemia or of toxicity; blood or brain homogenates of cured animals were non-infective to immunosuppressed animals. These studies indicate that this series of compounds, previously studied as antitumor agents, should be re-examined as potential trypanocides.

Author Notes

Copyright:
Copyright © 1984 by The American Society of Tropical Medicine and Hygiene 1984
Accepted:
09 Mar 1984
|
Published Online:
Sep 1984
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 3046 2739 457
Full Text Views 4 2 0
PDF Downloads 2 2 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save